After adjusting for age, gender, smoking, betel quid chewing, and stage, EIF5A2 expression remained statistically significant with the overall survival of oral cancer patients (HR = 1.714, 95% CI: 1.134–2.590, p = 0.011; Table 4). The gene discussed is EIF5A2; the disease is lip and oral cavity carcinoma.